| The dual role of bacteriocins as anti- and probiotics. | |
| | |
MedLine Citation:
|
PMID: 18853155 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
Bacteria employed in probiotic applications help to maintain or restore a host's natural microbial floral. The ability of probiotic bacteria to successfully outcompete undesired species is often due to, or enhanced by, the production of potent antimicrobial toxins. The most commonly encountered of these are bacteriocins, a large and functionally diverse family of antimicrobials found in all major lineages of Bacteria. Recent studies reveal that these proteinaceous toxins play a critical role in mediating competitive dynamics between bacterial strains and closely related species. The potential use of bacteriocin-producing strains as probiotic and bioprotective agents has recently received increased attention. This review will report on recent efforts involving the use of such strains, with a particular focus on emerging probiotic therapies for humans, livestock, and aquaculture. |
| | |
Authors:
|
O Gillor; A Etzion; M A Riley |
Related Documents
:
|
15156045 - Production of antimicrobial substances by lactic acid bacteria ii: screening bacterioci... 11302155 - Isolation and characterization of enterocin se-k4 produced by thermophilic enterococci,... 8060795 - Occurrence of listeria in hot and cold smoked seafood products. 16535615 - Vegetable-associated pediococcus parvulus produces pediocin pa-1. 23110085 - Prevalence of plasmid-mediated quinolone resistance and aminoglycoside resistance deter... 6763155 - Species and structural variations affecting pyrethroid neurotoxicity. |
Publication Detail:
|
Type: Journal Article; Research Support, N.I.H., Extramural; Review Date: 2008-10-14 |
Journal Detail:
|
Title: Applied microbiology and biotechnology Volume: 81 ISSN: 1432-0614 ISO Abbreviation: Appl. Microbiol. Biotechnol. Publication Date: 2008 Dec |
Date Detail:
|
Created Date: 2008-12-03 Completed Date: 2009-01-09 Revised Date: 2010-12-03 |
Medline Journal Info:
|
Nlm Unique ID: 8406612 Medline TA: Appl Microbiol Biotechnol Country: Germany |
Other Details:
|
Languages: eng Pagination: 591-606 Citation Subset: IM |
Affiliation:
|
Department of Environmental Hydrology & Microbiology, Zuckerberg Institute for Water Research, J. Blaustein Institutes for Desert Research, Ben-Gurion University of the Negev, Sde Boker Campus, Beersheba, 84990, Israel. |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Animals Anti-Bacterial Agents / pharmacology* Bacteria / classification, metabolism Bacterial Infections / drug therapy*, microbiology, veterinary* Bacteriocins / pharmacology* Humans Probiotics / pharmacology* |
| Grant Support | |
ID/Acronym/Agency:
|
R01 AI064588-01A2/AI/NIAID NIH HHS; R01 AI064588-02/AI/NIAID NIH HHS; R01A1064588-01A2//PHS HHS; R01GM068657-01A2/GM/NIGMS NIH HHS |
| Chemical | |
Reg. No./Substance:
|
0/Anti-Bacterial Agents; 0/Bacteriocins |
| Comments/Corrections | |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Stereospecificity of myo-inositol hexakisphosphate hydrolysis by a protein tyrosine phosphatase-like...
Next Document: Reinfusion of unwashed salvaged blood after total knee arthroplasty in patients with rheumatoid arth...